Pfizer Inc. (PFE) NYSE
27.76
+0.72(+2.66%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
27.76
+0.72(+2.66%)
Currency In USD
| Market Cap | 141.5B |
| Enterprise Value | 207.77B |
| P/E Ratio | 20.3 |
| PEG Ratio | -0.95 |
| Price/Sales Ratio | 2.52 |
| Price/Book Ratio | 1.82 |
| Enterprise/Revenue | 3.58 |
| Enterprise/EBITDA | 13.35 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0.12 |
| Operating Margin | 0.25 |
| Return On Assets | 0.04 |
| Return On Equity | 0.09 |
| Revenue | 62.58B |
| Revenue/Share | 11.01 |
| Gross Profit | 44.01B |
| EBITDA | 15.1B |
| Net Income | 7.77B |
| Diluted EPS | 1.36 |
| Total Cash | 13.6B |
| Total Cash/Share | 2.39 |
| Total Debt | 67.42B |
| Total Debt/Equity | 0.78 |
| Current Ratio | 1.16 |
| Book Value Per Share | 15.27 |
| 52-Week Change | 9.55 |
| 52-Week High | 27.94 |
| 52-Week Low | 20.92 |
| Moving Average 50 Days | 26.63 |
| Moving Average 200 Days | 25.3 |
| Average Volume | 45.34M |
| Shares Outstanding | 5.69B |
| % Held by Institutions | 65.57 |
| Trailing Annual Dividend Rate | 1.72 |
| Trailing Annual Dividend Yield | 6.2 |
| Payout Ratio | 1.26 |
| Last Split Factor | 527:500 |
| Last Split Date | November 17, 2020 |